Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis

Growth Factor ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Genomic Variation ◽

Epidermal Growth ◽

Nsclc Patients

Epidermal growth factor receptor mutations and their correlation with epidermal growth factor receptor-tyrosine kinase inhibitor therapy and association with the characteristics of patients with non-small-cell lung cancer: A meta-analysis

Thoracic Cancer ◽

10.1111/j.1759-7714.2011.00051.x ◽

2011 ◽

Vol 2 (3) ◽

pp. 101-108

Author(s):

Xiao-Hang Zhang ◽

Cheng Li ◽

Chen-Fei Dai ◽

Bao-Sen Zhou

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

PTU-174 Systematic review and meta-analysis of the influence of human epidermal growth factor receptor 2 (HER2) expression and amplification on survival in patients with oesophageal cancer

Gut ◽

10.1136/gutjnl-2012-302514c.174 ◽

2012 ◽

Vol 61 (Suppl 2) ◽

pp. A256.1-A256

Author(s):

D Chan ◽

C Twine ◽

W Lewis

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Oesophageal Cancer ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Her2 Expression ◽

Human Epidermal Growth Factor ◽

Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Clinical Lung Cancer ◽

10.1016/j.cllc.2014.11.002 ◽

2015 ◽

Vol 16 (3) ◽

pp. 228-236 ◽

Cited By ~ 10

Author(s):

Yoon Ki Cha ◽

Ho Yun Lee ◽

Myung-Ju Ahn ◽

Yoon-La Choi ◽

Ji Hyun Lee ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Tumor Burden ◽

Epidermal Growth ◽

Receptor Mutant

Faculty Opinions recommendation of Efficacy and safety of anti-epidermal growth factor receptor agents for the treatment of oesophageal cancer: a systematic review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739805508.793584158 ◽

2021 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Oesophageal Cancer ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

Frontiers in Oncology ◽

10.3389/fonc.2019.00132 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 10

Author(s):

Karen L. Reckamp ◽

Paul H. Frankel ◽

Nora Ruel ◽

Philip C. Mack ◽

Barbara J. Gitlitz ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii ◽

Kinase Inhibitor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Egfr Mutant

Efficacy of Afatinib, Erlotinib, and Gefitinib on epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients with brain metastasis: a network meta-analysis

10.1183/13993003.congress-2018.pa2802 ◽

2018 ◽

Author(s):

So-My Koo ◽

Ki-Up Kim ◽

Yang-Ki Kim ◽

Soo-Taek Uh

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Nsclc Patients

KRASstatus and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis

Colorectal Disease ◽

10.1111/codi.12749 ◽

2014 ◽

Vol 16 (11) ◽

pp. O370-O378 ◽

Cited By ~ 8

Author(s):

W. Li ◽

Q. Shi ◽

W. Wang ◽

J. Liu ◽

J. Ren ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment

Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2017.10.008 ◽

2018 ◽

Vol 62 ◽

pp. 1-8 ◽

Cited By ~ 23

Author(s):

Galileo A. Gonzalez-Conchas ◽

Laura Rodriguez-Romo ◽

David Hernandez-Barajas ◽

Juan F. Gonzalez-Guerrero ◽

Ivan A. Rodriguez-Fernandez ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Early Breast Cancer ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Intercalated combination of chemotherapy and epidermal growth factor receptor inhibitors for patients with advanced non-small-cell lung cancer: A systematic review and meta-analysis

Annals of Oncology ◽

10.1093/annonc/mdw383.58 ◽

2016 ◽

Vol 27 ◽

pp. vi436

Author(s):

A. Rossi ◽

A.L.a. Salvia ◽

D. Galetta ◽

E. Gobbini ◽

E. De Luca ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

A leopard can’t change its spots: can a T790M mutation-positive cancer change its spots after epidermal growth factor receptor-tyrosine kinase inhibitor therapy?

Journal of Thoracic Disease ◽

10.21037/jtd.2018.10.53 ◽

2018 ◽

Vol 10 (S33) ◽

pp. S4113-S4113

Author(s):

Kai Obayashi ◽

Kimihiro Shimizu ◽

Seshiru Nakazawa ◽

Yoichi Ohtaki ◽

Natsuko Kawatani ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

T790m Mutation ◽